Preventing Chemo Brain? Study Identifies Potential Approach for Common Problem
A side effect of some cancer treatments commonly referred to as “chemo brain” has received increasing attention from researchers lately. [...]
Groundbreaking Study on How Barrett’s Esophagus becomes Cancer
A new study from Great Britain underscores the importance of early detection of Barrett's Esophagus in the fight to stop [...]
A Survivor’s Story
Gary Gilbert of York, Pennsylvania was diagnosed with Stage III Esophageal Adenocarcinoma in 2010. This is his story.
She Dealt with the Anguish of Losing Her Dad to Esophageal Cancer …
And went on to win the Silver Medal in the Tokyo Olympics in the Women's 1500 Meter competition! Erica Sullivan [...]
Small but Mighty, ECAN turns 12
Twelve years ago, a small but mighty group of dedicated folks who wanted to see significant change for patients [...]
Three New Immunotherapy Indications for Esophageal Cancer Patients
Since March 2021, the U.S. Food and Drug Administration has issued four approvals for PD-L1 Inhibitors for patients with Esophageal [...]
A Reason for Optimism
This is the 13th anniversary of my husband's death. It may sound like a contradiction, but it is a reason [...]
ECAN Experts cited in US News & World Report
"Esophageal Cancer: What to Know" is a new report from U.S. News & World Report by contributing writer David Levine. [...]
FDA Fast-Tracks Review of 3 New Immunotherapy Options for Esophageal Cancer Patients
The U.S. Food & Drug Administration has granted Priority Review for the use of immunotherapies in three new designations for [...]
New Treatment Option for Patients with HER2+ Gastroesophageal Junction Adenocarcinoma
The U.S. Food & Drug Administration has approved a new therapy for adult patients with locally advanced or metastatic HER2+ [...]